These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30916034)

  • 1. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.
    Ogawa S; Ohnishi T; Hosokawa K; Szlam F; Chen EP; Tanaka KA
    Br J Anaesth; 2013 Dec; 111(6):1013-23. PubMed ID: 23794670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro.
    Thomas KA; Shea SM; Spinella PC
    Transfusion; 2021 Jun; 61(6):1943-1954. PubMed ID: 33755208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
    Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
    Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
    Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.
    Bolliger D; Szlam F; Molinaro RJ; Rahe-Meyer N; Levy JH; Tanaka KA
    Br J Anaesth; 2009 Jun; 102(6):793-9. PubMed ID: 19420005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
    Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
    Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.
    Caballo C; Escolar G; Diaz-Ricart M; Lopez-Vílchez I; Lozano M; Cid J; Pino M; Beltrán J; Basora M; Pereira A; Galan AM
    Blood Transfus; 2013 Jul; 11(3):391-9. PubMed ID: 23058866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of coagulation abnormalities among women with vaginal bleeding in the first trimester of pregnancy.
    Kovač V; Vlaisavljević V; Reljič M
    Int J Gynaecol Obstet; 2012 Sep; 118(3):202-4. PubMed ID: 22727417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women.
    Kristoffersen AH; Petersen PH; Bjørge L; Røraas T; Sandberg S
    Clin Chem Lab Med; 2018 Jul; 56(8):1297-1308. PubMed ID: 29648994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.
    Tanaka KA; Terada R; Butt AL; Mazzeffi MA; McNeil JS
    Anesth Analg; 2023 May; 136(5):894-904. PubMed ID: 37058725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.
    Szanto T; Nummi V; Jouppila A; Brinkman HJM; Lassila R
    Platelets; 2020; 31(1):103-111. PubMed ID: 30836803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
    Winstedt D; Tynngård N; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C; Calatzis A; Welsch U; Heindl B
    Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage.
    Bolliger D; Szlam F; Levy JH; Molinaro RJ; Tanaka KA
    Br J Anaesth; 2010 Mar; 104(3):318-25. PubMed ID: 20133450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
    Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
    J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.